Issues related to price transparency and site-neutral payment reforms to reduce out-of-pocket costs for patients with blood cancer.
2026 · 2nd Quarter (Apr 1 - June 30)
BLOOD CANCER UNITED, INC. (FKA LEUKEMIA & LYMPHOMA SOCIETY, INC. (LLS)
Filed by CROSSROADS STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- CROSSROADS STRATEGIES, LLC
- Filing UUID
- 41be55f8-dd99-4b87-aea9-3df84bc75013
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.